Ruslan Chernetsov
Ruslan Chernetsov has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alena Grechman
Южно-Уральский государственный медицинский университет, Российская Федерация, 454092, Челябинск, ул. Воровского, 64
1 shared publication Aliya Bekmurzaeva
Сургутский государственный университет, Российская Федерация, 628412, Сургут, пр. Ленина, 1
1 shared publication- D.I. Kiseleva
Pirogov Russian National Research Medical University
1 shared publication Denis Burmistrov
Российский университет дружбы народов имени Патриса Лумумбы, Российская Федерация, 117198, Москва, ул. Миклухо-Маклая, 6
1 shared publication- Dmitriy V. Melnikov
Institute of Plastic Surgery and Cosmetology
1 shared publication - Natalia Evgenievna Manturova
N.I. Pirogov Russian National Research Medical University
1 shared publication
Latest Publications
- 21 May 2026
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 2
Outcomes of surgical correction for congenital breast asymmetry
Objective. To compare the effectiveness of symmetrical mastopexy with different-sized Mentor and Motiva implants versus asymmetric surgical techniques in correction of congenital breast asymmetry. Material and methods. A prospective cohort study included 28 patients with congenital breast asymmetry who underwent surgery in 2021—2025. The main group (n=20) underwent symmetrical mastopexy (identical procedure on both breasts) with different-sized implants. The control group (n=8) underwent asymmetric procedures (different types of mastopexy and/or incisions) also with different-sized implants. Morphometric parameters (sternal notch-to-nipple distance, nipple-to-inframammary fold distance, midline-to-nipple distance, areola diameter, breast footprint width), patient satisfaction (BREAST-Q), complication and redo surgery rates were assessed. Nonparametric methods (Mann—Whitney U test, Wilcoxon signed-rank test) were used. Data were presented as median and interquartile range Me [Q1; Q3]. Results. In the main group, postoperative absolute differences between sides were 0—0.1 cm for all parameters. The control group retained residual differences in nipple-to-inframammary fold distance (0.3 [0.1; 0.7] cm) and midline-to-nipple distance (0.2 [0.1; 0.4] cm) (p<0.05). The median BREAST-Q score at 6 months was 99.0 [98.0; 100] and 89.0 [85.0; 93.0], respectively (p<0.01). Redo surgeries were performed in 5 (25.0%) and 3 (37.5%) patients, respectively. Areola corrections dominated in the main group (4 out of 5). In the control group, implant exchange and areola corrections were carried out in 1 and 2 cases, respectively. No capsular contracture or infectious complications occurred. Conclusion. Symmetrical mastopexy with different-sized implants provides more accurate restoration of symmetry compared to asymmetric procedures with comparable satisfaction and acceptable redo surgery rate.
- 21 May 2026
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 2
Outcomes of surgical correction for congenital breast asymmetry
Objective. To compare the effectiveness of symmetrical mastopexy with different-sized Mentor and Motiva implants versus asymmetric surgical techniques in correction of congenital breast asymmetry. Material and methods. A prospective cohort study included 28 patients with congenital breast asymmetry who underwent surgery in 2021—2025. The main group (n=20) underwent symmetrical mastopexy (identical procedure on both breasts) with different-sized implants. The control group (n=8) underwent asymmetric procedures (different types of mastopexy and/or incisions) also with different-sized implants. Morphometric parameters (sternal notch-to-nipple distance, nipple-to-inframammary fold distance, midline-to-nipple distance, areola diameter, breast footprint width), patient satisfaction (BREAST-Q), complication and redo surgery rates were assessed. Nonparametric methods (Mann—Whitney U test, Wilcoxon signed-rank test) were used. Data were presented as median and interquartile range Me [Q1; Q3]. Results. In the main group, postoperative absolute differences between sides were 0—0.1 cm for all parameters. The control group retained residual differences in nipple-to-inframammary fold distance (0.3 [0.1; 0.7] cm) and midline-to-nipple distance (0.2 [0.1; 0.4] cm) (p<0.05). The median BREAST-Q score at 6 months was 99.0 [98.0; 100] and 89.0 [85.0; 93.0], respectively (p<0.01). Redo surgeries were performed in 5 (25.0%) and 3 (37.5%) patients, respectively. Areola corrections dominated in the main group (4 out of 5). In the control group, implant exchange and areola corrections were carried out in 1 and 2 cases, respectively. No capsular contracture or infectious complications occurred. Conclusion. Symmetrical mastopexy with different-sized implants provides more accurate restoration of symmetry compared to asymmetric procedures with comparable satisfaction and acceptable redo surgery rate.
- 1 January 2024
- Published by Saint Petersburg State University in Vestnik of Saint Petersburg University. Medicine
- Vol. 19 (3) , 265-277
Antibiotic resistance and new antimicrobial strategies: Exploring the problem of antibiotic resistance and the development of new drugs
Antibiotic resistance represents a serious global threat to the effectiveness of antibacterial therapy and public health as a whole, requiring immediate attention from researchers, healthcare professionals, pharmaceutical companies, and governmental organizations. This review provides a detailed analysis of the primary mechanisms of antibiotic resistance, including ef-flux pumps, enzymatic inactivation of antibiotics, changes in cellular targets, and biofilms, which play a key role in protecting bacteria from external influences and contribute to their survival. Alternative strategies for developing new antimicrobial agents aimed at overcoming these mechanisms and preventing further spread of resistance are also discussed. Special emphasis is placed on innovative approaches such as phage therapy, the use of antimicrobial peptides, nanoantibiotics, immune therapy methods, and CRISPR-Cas technologies, which offer new prospects for overcoming resistance. The review examines new drug candidates that require further study of their effectiveness, interactions with bacteria, and the use of biomaterials and nanoparticles for delivery. Possible ways to improve the efficiency of clinical trials of new drugs are analyzed. The importance of attracting private and public funding to support research is emphasized.
- 1 January 2024
- Published by Saint Petersburg State University in Vestnik of Saint Petersburg University. Medicine
- Vol. 19 (3) , 265-277
Antibiotic resistance and new antimicrobial strategies: Exploring the problem of antibiotic resistance and the development of new drugs
Antibiotic resistance represents a serious global threat to the effectiveness of antibacterial therapy and public health as a whole, requiring immediate attention from researchers, healthcare professionals, pharmaceutical companies, and governmental organizations. This review provides a detailed analysis of the primary mechanisms of antibiotic resistance, including ef-flux pumps, enzymatic inactivation of antibiotics, changes in cellular targets, and biofilms, which play a key role in protecting bacteria from external influences and contribute to their survival. Alternative strategies for developing new antimicrobial agents aimed at overcoming these mechanisms and preventing further spread of resistance are also discussed. Special emphasis is placed on innovative approaches such as phage therapy, the use of antimicrobial peptides, nanoantibiotics, immune therapy methods, and CRISPR-Cas technologies, which offer new prospects for overcoming resistance. The review examines new drug candidates that require further study of their effectiveness, interactions with bacteria, and the use of biomaterials and nanoparticles for delivery. Possible ways to improve the efficiency of clinical trials of new drugs are analyzed. The importance of attracting private and public funding to support research is emphasized.